TREM2 and Alzheimer disease: Triggering receptor expressed on myeloid cells 2 (TREM2) is recently considered as second genetic risk factor only followed APOE4 in AD, it is a transmembrane protein from the immunoglobulin superfamily and mainly expressed on microglia in the CNS [7, 8].